BusinessDermira Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate UpdateBy Nasdaq OMXMar 3, 2016, 12:30 PM UTC
BusinessDermira to Report Fourth Quarter and Full Year 2015 Financial ResultsBy Nasdaq OMXMar 1, 2016, 9:05 PM UTC
BusinessDermira to Present at Cowen and Company 36th Annual Health Care ConferenceBy Nasdaq OMXMar 1, 2016, 12:30 PM UTC
BusinessDermira Completes Patient Enrollment for DRM04 Phase 3 Pivotal Trials in Primary Axillary HyperhidrosisBy Nasdaq OMXFeb 29, 2016, 12:30 PM UTC
BusinessDermira Completes Patient Enrollment for Third CIMZIA® (certolizumab pegol) Phase 3 Clinical Trial in Psoriasis Program and Updates Guidance for Release of Topline DataBy Nasdaq OMXJan 8, 2016, 6:00 AM UTC
BusinessDermira Provides DRM01 and DRM04 Development Program UpdatesBy Nasdaq OMXJan 7, 2016, 9:05 PM UTC
